NDC 51662-1346

CLONIDINE HCI

Clonidine Hci

CLONIDINE HCI is a Intravenous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Hf Acquisition Co Llc, Dba Healthfirst. The primary component is Clonidine Hydrochloride.

• Product ID: 51662-1346_7daa1996-eaa0-2576-e053-2991aa0a6be5
• NDC: 51662-1346
• Product Type: Human Prescription Drug
• Proprietary Name: CLONIDINE HCI
• Generic Name: Clonidine Hci
• Dosage Form: Injection, Solution
• Route of Administration: INTRAVENOUS
• Marketing Start Date: 2018-12-23
• Marketing Category: ANDA / ANDA
• Application Number: ANDA200300
• Labeler Name: HF Acquisition Co LLC, DBA HealthFirst
• Substance Name: CLONIDINE HYDROCHLORIDE
• Active Ingredient Strength: 100 ug/mL
• Pharm Classes: Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
• NDC Exclude Flag: N
• Listing Certified Through: 2019-12-31

Packaging

NDC 51662-1346-1

1 VIAL, SINGLE-USE in 1 BOX (51662-1346-1) > 10 mL in 1 VIAL, SINGLE-USE

• Marketing Start Date: 2018-12-23
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 51662-1346-1 [51662134601]

CLONIDINE HCI INJECTION, SOLUTION

• Marketing Category: ANDA
• Application Number: ANDA200300
• Product Type: HUMAN PRESCRIPTION DRUG
• Marketing Start Date: 2018-12-23
• Inactivation Date: 2020-01-31
• Reactivation Date: 2020-02-07

Drug Details

Active Ingredients

Ingredient	Strength
CLONIDINE HYDROCHLORIDE	100 ug/mL

OpenFDA Data

• SPL SET ID: 7daa1996-ea9f-2576-e053-2991aa0a6be5
• Manufacturer:
  • HF Acquisition Co LLC, DBA HealthFirst
• UNII:
  • W76I6XXF06
• RxNorm Concept Unique ID - RxCUI:
  • 884221

Pharmacological Class

• Adrenergic alpha2-Agonists [MoA]
• Central alpha-2 Adrenergic Agonist [EPC]